ArticleEXCLI journal2020

Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis.

Chong-Woo Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.